Valiant Organics Limited · NSE:VALIANTORG
Valiant Organics — Q4 FY2024 Earnings Presentation
24 slides from Valiant Organics's earnings presentation, May 31, 2024
Slide 1: Cover letter to stock exchanges
May 31, 2024 To, To, Listing/Compliance Department Listing/Compliance Department BSE LTD National Stock Exchange of Phiroze Jeejeebhoy Towers, India Limited Dalal Street, “Exchange Plaza”, Plot No. C/1, Mumbai- 400 001. G Block Bandra-Kurla Complex, Bandra (E), Mumbai- 400 051 . SCRIP CODE - 540145
Slide 2: Earnings Presentation Q4-FY24/FY24
Earnings Presentation | Q4-FY24/FY24
Slide 3: Snapshot
SNAPSHOT One of the largest chlorophenol One of the leading manufacturer of derivatives manufacturer globally Benzene derivatives products One of the largest domestic PNA One of the few commercial players in manufacturer Ortho Anisidine and Para Anisidine Diversified client base across Amongst 1st f
Slide 4: Company Overview
Company Overview Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India. The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmac
Slide 5: Chemistries And Product Basket
Chemistries And Product Basket FY24 Revenue Share Hydrogenation Ammonolysis 41% Key Products: Industries Served: Key Products: Industries Served: • Ortho Anisidine • Dyes • Para Nitro Aniline • Para Anisidine • Dyes • Pigments • Ortho Chloro Para Nitro Aniline • IPPCA • Pigments • Pharmaceutical • M
Slide 6: Manufacturing Footprint
Manufacturing Footprint CHLORINATION – SARIGAM HYDROGENATION & METHOXYLATION- • Capacity: 18,000 MTPA JHAGADIA UNIT 1 • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • Capacity: 27,000 MTPA 2,4,6 TCP • Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS AMMONOLYSIS - VAPI HYDROGENATION – JHAGADIA UNIT 2 •
Slide 7: Key Strengths
Key Strengths Domain expertise and broad Plant locations are process understanding in a Wide supply chain strategically located near variety of chemistries. The provides the continuous ports to provide a executive team is made up of availability of adequate competitive advantage, first-generation te
Slide 8: Q4-FY24/FY24 Highlights
Q4-FY24/FY24 HIGHLIGHTS Valiant Organics Limited | Q4-2024 7
Slide 9: Consolidated Financial Highlights
CONSOLIDATED FINANCIAL HIGHLIGHTS Q4-FY24 CONSOLIDATED FINANCIAL HIGHLIGHTS FY24 CONSOLIDATED FINANCIAL HIGHLIGHTS INR 1,768 Mn INR 7,231 Mn Operational Revenue Operational Revenue INR (18) Mn INR 382 Mn Operating EBITDA Operating EBITDA (1.02)% 5.28% Operating EBITDA Margin Operating EBITDA Margin
Slide 10: Q4-FY24/FY24 Operational Highlights
Q4-FY24/FY24 Operational Highlights • Sales volumes increased by 15% YoY in Q4-FY24 due to improvement in demand of dyes Q4-FY24 Revenue Break-up – Chemistries & pigments. Others, 4% • The overall performance for the quarter was under stress mainly from continued pricing Chlorination, pressure. 22%
Slide 11: Key Chemistries Revenues and Sales Volumes
Key Chemistries Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn) 1,045 1, 200 700 612 582 160 138 579 700 1, 000 REVENUES 140 600 600 105 668 404 120 500 800 500 379 605 366 73 100 400 400 600 80 300 300 60 400 200 200 40 200 100 100 20 0 0 0 0 Q4-FY23 Q3-FY24 Q4-FY2
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance Particulars (INR Mn) Q4-FY24 Q4-FY23 Y-o-Y Q3-FY24 Q-o-Q Revenue from Operations 1,768 2,714 (34.9)% 1,414 25.0% Total Expenses 1,786 2,191 (18.5)% 1,376 29.8% EBITDA (18) 523 NA 38 NA EBITDA Margins (%) (1.02)% 19.27% NA 2.69% (371) bps Other Income 21 2
Slide 13: Annual Consolidated Financial Performance
Annual Consolidated Financial Performance Particulars (INR Mn) FY24 FY23 Y-o-Y Revenue from Operations 7,231 10,518 (31.3)% Total Expenses 6,849 8,875 (22.8)% EBITDA 382 1,643 (76.7)% EBITDA Margins (%) 5.28% 15.62% NA Other Income 93 80 16.3% Depreciation 349 292 19.5% Finance Cost 163 108 50.9% Pr
Slide 14: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance Particulars (INR Mn) Q4-FY24 Q4-FY23 Y-o-Y Q3-FY24 Q-o-Q Revenue from Operations 1,768 2,272 (22.2)% 1,414 25.0% Total Expenses 1,786 1,831 (2.5)% 1,376 29.8% EBITDA (18) 441 NA 38 NA EBITDA Margins (%) (1.02)% 19.41% NA 2.69% (371) bps Other Income 21 6 NA
Slide 15: Annual Standalone Financial Performance
Annual Standalone Financial Performance Particulars (INR Mn) FY24 FY23 Y-o-Y Revenue from Operations 6,772 9,116 (25.7)% Total Expenses 6,376 7,817 (18.4)% EBITDA 396 1,299 (69.5)% EBITDA Margins (%) 5.85% 14.25% (840) bps Other Income 29 29 NA Depreciation 340 276 23.2% Finance Cost 194 105 84.8% P
Slide 16: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW Valiant Organics Limited | Q4-2024 15
Slide 17: Historical Consolidated Income Statement
Historical Consolidated Income Statement Particulars (INR Mn) FY21 FY22 FY23 FY24 Revenue from Operations 7,548 11,533 10,518 7,231 Total Expenses 5,496 9,484 8,875 6,849 EBITDA 2,052 2,049 1,643 382 EBITDA Margins (%) 27.19% 17.77% 15.62% 5.28% Other Income 59 74 80 93 Depreciation 212 296 292 349
Slide 18: Consolidated Balance Sheet
Consolidated Balance Sheet Particulars (INR Mn) FY22 FY23 FY24 Particulars (INR Mn) FY22 FY23 FY24 EQUITY 6,489 7,401 7,293 Non-Current Assets 6,652 7,682 8,352 a) Equity Share Capital 272 272 276 a) Property, Plant and Equipment 5,303 6,565 6,297 b) Other Equity 5,856 6,616 7,017 c) Right-Of-Use As
Slide 19: Historical Standalone Income Statement
Historical Standalone Income Statement Particulars (INR Mn) FY21 FY22 FY23 FY24 Revenue from Operations 5,742 9,484 9,116 6,772 Total Expenses 4,170 7,811 7,817 6,376 EBITDA 1,572 1,673 1,299 396 EBITDA Margins (%) 27.38% 17.64% 14.25% 5.85% Other Income 169 33 29 29 Depreciation 186 273 276 340 Fin
Slide 20: Standalone Balance Sheet
Standalone Balance Sheet Particulars (INR Mn) FY22 FY23 FY24 Particulars (INR Mn) FY22 FY23 FY24 EQUITY 6,031 6,661 6,649 Non-Current Assets 6,787 7,424 7,818 a) Equity Share Capital 272 272 276 a) Property, Plant and Equipment 5,085 6,092 6,297 b) Other Equity 5,755 6,385 6,373 b) Right-Of-Use Asse
Slide 21: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins (%) PAT (INR Mn) & PAT Margins (%) 14, 000 2,052 2,049 80.00% 11,533 2,100 70.00% 10,518 12, 000 1,800 1,643 1,309 1,279 60.00% 1, 400 10, 000 1,500 50.00% 1,026 8, 000 7,548 7,231 1, 100 1,200 40.00% 27.
Slide 22: Capital Market Information
Capital Market Information Share Price up to 31st March, 2024 50% 30% 10% -10% -30% -50% -70% Apr-27 May-27 Jun-27 Jul-27 Aug-27 Sep-27 Oct-27 Nov-27 Dec-27 Jan-28 Feb-28 Mar-28 Valiant Organics Sensex Price Data (As on 31st March, 2024) INR Shareholding pattern (As on 31st March, 2024) FII; 1.14% D
Slide 23: Disclaimer
Disclaimer Valiant Organics Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all event
Slide 24: Thank You
THANK YOU Valiant Organics Limited | Q4-2024 23